关键词:
                            
                                
                                    Cytokines
                                
                                 
                                    Cytokine therapy
                                
                                 
                                    Vitamin D
                                
                                 
                                    Serum proteins
                                
                                 
                                    Multiple sclerosis
                                
                                 
                                    Antiviral therapy
                                
                                 
                                    Chemokines
                                
                                 
                                    Interferons
                                
                     
                    
                    
                    
                            摘要:
Introduction Dysfunctional regulatory T cells and subnormal responses to interferon-beta disrupt the immune system in multiple sclerosis. We probed dysregulated type I IFN pathways in vitro and in vivo IFN-beta to induce transcription factors, cytokines, and neurotrophic *** 36 MS-relevant serum proteins curated to be relevant to MS were detected with multiplex and IFN activity assays plus western blots of mononuclear cells from 15 partial responders (PR) to IFN-beta therapy with exacerbations over five years of treatment, and 12 clinical responders (CR) without exacerbations. Response was measured 0, 4, and 24 hours after injection of 16 million units (MU) of IFN-beta (double-dose) and 8 MU (standard dose), in clinically stable PR and CR, and 16 MU IFN-beta in paired PR during exacerbations, an IFN-resistant state. IFN-beta effects after therapy washout were compared to 15 therapy-na & iuml;ve stable and 13 active RRMS and 18 healthy controls (HC).Results IFN-beta injection corrected subnormal levels of p-S-STAT1 transcription factor and induced antiviral MxA and type I IFNs. IFN-beta induced anti-inflammatory IL-4, IL-10, IL-12p40, and TNFRII more strongly in stable PR than CR. Th2 cytokines correlated with serum vitamin D levels in CR. During exacerbations, IFN-beta injections induced Th1, Th2, and neurotropic proteins. After therapy washout, serum IFN-alpha/beta and pro-inflammatory IL-12p70 levels were lower in stable CR than in PR. In therapy-na & iuml;ve MS, Th1, Th2, and neurotrophic protein levels were surprisingly subnormal and poorly intercorrelated. Long-term IFN-beta therapy elevated serum proteins and brought them to a balanced positively-correlated state, echoing *** IFN-beta corrects low serum type I IFN levels, enhances responses to subsequent IFN exposure, induces immunoregulatory and neuroprotective proteins, and balances dysregulated and subnormal serum cytokine levels. Low serum IFN and IFN-beta-induced proteins link to be